top of page

Process
Technology
Partnerships
Case Studies & Pipeline
News
Contact
About
More

Use tab to navigate through the menu items.

Dark background with hint of blue abstract data.jpg

News

Subscribe to Newsletter

Qubigen Wraps Up BIO 2025 with Over 40 Strategic Meetings and High-Impact Engagements

Qubigen Wraps Up BIO 2025 with Over 40 Strategic Meetings and High-Impact Engagements

Qubigen Wraps Up BIO 2025 with Over 40 Strategic Meetings and High-Impact Engagements

Qubigen has concluded a highly productive week in Boston focused on partnering and collaboration, highlighted by CEO Jonathan Hall’s...

Jul 4, 20251 min read

Qubigen and the University of Melbourne Sign Memorandum of Understanding to Explore Drug Development Collaboration

Qubigen and the University of Melbourne Sign Memorandum of Understanding to Explore Drug Development Collaboration

Qubigen and the University of Melbourne Sign Memorandum of Understanding to Explore Drug Development Collaboration

Qubigen is pleased to announce the signing of a Memorandum of Understanding (MoU) with the University of Melbourne, marking the beginning of a potential strategic collaboration for small molecule drug development.

May 30, 20251 min read

Qubigen Joins the TBXT Challenge to Accelerate Discovery of Lead Candidates for Chordoma

Qubigen Joins the TBXT Challenge to Accelerate Discovery of Lead Candidates for Chordoma

Qubigen Joins the TBXT Challenge to Accelerate Discovery of Lead Candidates for Chordoma

Qubigen is proud to announce its participation in the TBXT Challenge, a global initiative to develop lead drug candidates targeting the...

May 30, 20251 min read

enquiries@qubigen.com

Bio21 Institute

30 Flemington Road

Parkville VIC 3052

Australia

Accelerate drug design
without exposing secrets

Connect with Us

© 2025 Qubigen. All rights reserved.

bottom of page